Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

1.9K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

56
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
56
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

550
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
550
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

91
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
91
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

51
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
51
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

79
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
79

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exercise training for cardiovascular prevention in patients with cancer.

European heart journal·2026
Same author

Threshold Effects, Cognitive Decline, and Longitudinal Changes in White Matter Hyperintensity Volume.

Stroke·2026
Same author

The reliability and accuracy of recombination inferred by Shapeit2 duoHMM on whole genome sequence.

bioRxiv : the preprint server for biology·2026
Same author

Formate reduces ischemic injury in the male heart by increasing protein <i>S</i> -nitrosation.

bioRxiv : the preprint server for biology·2026
Same author

Glucose Disposal Rate: A Novel Measure of Insulin Resistance Associated With Myocardial Fibrosis and Incident Heart Failure.

Journal of the American Heart Association·2026
Same author

Outcomes in skilled nursing facilities versus other locations in outpatient parenteral antimicrobial therapy among patients with substance use disorders.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2026

Related Experiment Video

Updated: Oct 4, 2025

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

324

Mitochondrial Creatine Kinase Attenuates Pathologic Remodeling in Heart Failure.

Gizem Keceli1, Ashish Gupta1, Joevin Sourdon1

  • 1Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD (G.K., A.G., J.S., J.A., M.L., B.O., G.G., N.P., R.G.W.).

Circulation Research
|February 3, 2022
PubMed
Summary

Heart failure is linked to impaired creatine kinase (CK) energy metabolism. Rescuing mitochondrial CK (CKmito) in experimental heart failure attenuated maladaptive hypertrophy, suggesting CKmito

Keywords:
antioxidantscreatinedilatationheart failuremyofibrils

More Related Videos

A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure
07:13

A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure

Published on: April 30, 2020

6.6K
A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

21.1K

Related Experiment Videos

Last Updated: Oct 4, 2025

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

324
A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure
07:13

A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure

Published on: April 30, 2020

6.6K
A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

21.1K

Area of Science:

  • Cardiology
  • Biochemistry
  • Metabolic Research

Background:

  • Heart failure (HF) involves cardiac energy metabolism abnormalities contributing to contractile dysfunction.
  • The role of creatine kinase (CK), a key energy reserve, in HF-related remodeling is less understood.
  • CK is downregulated in experimental and human HF, impacting ATP regeneration.

Purpose of the Study:

  • To investigate the relationship between impaired cardiac CK energy metabolism and pathologic remodeling in human HF.
  • To determine if rescuing CK function can attenuate maladaptive hypertrophy in experimental HF.

Main Methods:

  • Noninvasive magnetic resonance 31P spectroscopy and MRI were used to measure cardiac energetics and remodeling in HF patients and healthy subjects.
  • Cardiac-specific overexpression of myofibrillar CK (Ckmyofib) or mitochondrial CK (Ckmito) was tested in mouse models of HF.

Main Results:

  • In humans, pathologic left ventricular hypertrophy and dilatation correlated with reduced ATP levels and CK-dependent ATP synthesis.
  • In mice, CKmito overexpression attenuated hypertrophy and dilatation in response to transverse aortic constriction and isoproterenol stimulation.
  • CKmito overexpression reduced reactive oxygen species and upregulated antioxidants, with protection lost upon creatine depletion, highlighting the importance of ADP regeneration.

Conclusions:

  • Pathologic hypertrophy and remodeling in human HF are linked to deficits in ATP levels and the CK energy reserve.
  • Mitochondrial CK (CKmito) plays a critical role in attenuating pathologic HF remodeling by influencing cardiac energetics and redox balance.